CLSD logo

Clearside Biomedical, Inc. (CLSD)

Profile

Full Name

Clearside Biomedical, Inc.

Ticker

NASDAQ: CLSD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 2, 2016

Indexes

Not included

Website

https://clearsidebio.com

Employees

32

Key Details

Price

$4.10(+1181.25%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.66M(-79.77% YoY)

Annual EPS

-$0.47(+11.32% YoY)

PE ratio

-

Next earnings date

Sep 15, 2025

Next ex-dividend date

N/A

Next split date

Sep 15, 2025

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.10
    CLSD price is $4.10

    30-Day Relative Volume

    0.88
    CLSD 30-day relative volume is 0.88

    Price Performance

    Price Today change

    +1181.25%
    CLSD price is up +1181.25% today

    Price YTD change

    +331.58%
    CLSD price is up +331.58% since January 1st

    Price 1-year change

    +233.33%
    CLSD price is up +233.33% year-on-year

    Price 3-year change

    +210.61%
    CLSD price is up +210.61% over the past 3 years

    Price Range

    Price All-time high

    $25.08
    CLSD price is currently -83.65% below its historical high of $25.08

    Price 3-year low

    $0.29
    CLSD price is currently +1304.11% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $21.46M
    CLSD market capitalization is $21.46 million

    Market cap 3-year change

    +305.14%
    CLSD market capitalization is up +305.14% over the past 3 years

    Market cap All-time high

    $33.86M
    CLSD market capitalization is currently -36.62% below its historical high of $33.86 million

    Market cap sector rank

    22.99%
    CLSD market capitalization is higher than 22.99% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.04%
    CLSD shares outstanding is up +5.04% year-on-year

    Shares Outstanding 3-Year Change

    +30.44%
    CLSD shares outstanding is up +30.44% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.70
    CLSD beta is 1.70

    200-day SMA

    $0.82
    CLSD price is currently +401.04% above its 200-day simple moving average

    50-day SMA

    $0.55
    CLSD price is currently +645.32% above its 50-day simple moving average

    RSI

    96.25
    CLSD 14-day relative strength index is 96.25

    Volume

    0.88
    CLSD 30-day relative volume is 0.88

    ATR

    $0.33
    CLSD average true range is $0.33

    10-day Historical Volatility

    5764.95%
    CLSD 10-day historical volatility is 5764.95%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.66M
    CLSD annual revenue is $1.66 million

    Revenue Analysts estimate

    $3.19M
    CLSD annual revenue is currently -47.91% lower than the consensus analysts' forecast

    Revenue 1-year change

    -79.77%
    CLSD annual revenue is down -79.77% year-on-year

    Revenue Sector rank

    38.77%
    CLSD annual revenue is higher than 38.77% of companies in Healthcare sector

    EPS

    EPS

    -$0.47
    CLSD annual earnings per share is -$0.47

    EPS Analysts estimate

    -$0.30
    CLSD annual earnings per share is currently +54.96% higher than the consensus analysts' forecast

    EPS 1-year change

    +11.32%
    CLSD annual earnings per share is up +11.32% year-on-year

    EPS Sector rank

    63.53%
    CLSD annual earnings per share is higher than 63.53% of companies in Healthcare sector

    Profit

    Gross profit

    $1.29M
    CLSD annual gross profit is $1.29 million

    Gross margin

    77.46%
    CLSD annual gross profit margin is 77.46%

    Operating profit

    -$28.88M
    CLSD annual operating income is -$28.88 million

    Operating margin

    -1735.70%
    CLSD annual operating profit margin is -1735.70%

    Net income

    -$34.35M
    CLSD annual net profit is -$34.35 million

    Net margin

    -2064.42%
    CLSD annual net profit margin is -2064.42%

    Expenses

    Total expenses

    $36.02M
    CLSD annual total expenses is $36.02 million

    Operating expenses

    $30.17M
    CLSD annual total operating expenses is $30.17 million

    Cost of goods sold

    $375.00K
    CLSD annual cost of goods sold is $375.00 thousand

    Selling, general & administrative expenses

    $0.00
    CLSD annual SGA is $0.00

    Depreciation and amortization

    $226.00K
    CLSD annual depreciation & amortization is $226.00 thousand

    Interest expense

    $0.00
    CLSD annual interest expense is $0.00

    Income tax

    $0.00
    CLSD annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$28.88M
    CLSD annual earnings before interest & taxes is -$28.88 million

    EBITDA

    -$28.66M
    CLSD annual EBITDA is -$28.66 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $25.13M
    CLSD annual total assets is $25.13 million

    Non current assets

    $3.85M
    CLSD annual long term assets is $3.85 million

    Current assets

    $21.27M
    CLSD annual total current assets is $21.27 million

    Cash and cash equivalents

    $20.02M
    CLSD annual cash & cash equivalents is $20.02 million

    Accounts receivable

    $507.00K
    CLSD annual accounts receivable is $507.00 thousand

    Inventory

    $0.00
    CLSD annual inventory is $0.00

    Liabilities

    Total liabilities

    $63.98M
    CLSD annual total liabilities is $63.98 million

    Long term liabilities

    $59.19M
    CLSD annual total long term liabilities is $59.19 million

    Current liabilities

    $4.79M
    CLSD annual total current liabilities is $4.79 million

    Accounts payable

    $1.45M
    CLSD annual accounts payable is $1.45 million

    Debt

    Total debt

    $52.47M
    CLSD annual total debt is $52.47 million

    Total debt 1-year change

    +22.02%
    CLSD annual total debt is up +22.02% year-on-year

    Long term debt

    $52.09M
    CLSD annual long term debt is $52.09 million

    Short term debt

    $375.00K
    CLSD annual short term debt is $375.00 thousand

    Equity & Capital

    Shareholders equity

    -$38.85M
    CLSD annual stockholders equity is -$38.85 million

    Book value

    -$38.86M
    CLSD annual book value is -$38.86 million

    Retained earnings

    -$355.27M
    CLSD annual retained earnings is -$355.27 million

    Working capital

    $16.48M
    CLSD annual working capital is $16.48 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$24.70M
    CLSD annual cash flow from operations is -$24.70 million

    Cash from operations 1-year change

    -36.19%
    CLSD annual cash flow from operations is down -36.19% year-on-year

    Cash from investing

    -$638.00K
    CLSD annual cash flow from investing activities is -$638.00 thousand

    Cash from investing 1-year change

    +64.1%
    CLSD annual cash flow from investing activities is up +64.1% year-on-year

    Cash from financing

    $16.44M
    CLSD annual cash flow from financing activities is $16.44 million

    Cash from financing 1-year change

    +3870.05%
    CLSD annual cash flow from financing activities is up +3870.05% year-on-year

    CAPEX

    CAPEX

    $977.00K
    CLSD annual capital expenditures is $977.00 thousand

    CAPEX 1-year change

    -45.02%
    CLSD annual capital expenditures is down -45.02% year-on-year

    Free Cash Flow

    Free cash flow

    -$25.68M
    CLSD annual free cash flow is -$25.68 million

    Free cash flow 1-year change

    -28.94%
    CLSD annual free cash flow is down -28.94% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    77.46%
    CLSD annual gross profit margin is 77.46%

    Operating margin

    -1735.70%
    CLSD annual operating profit margin is -1735.70%

    Net margin

    -2064.42%
    CLSD annual net profit margin is -2064.42%

    ROA & ROE

    ROA

    -116.16%
    CLSD annual return on assets is -116.16%

    ROE

    88.41%
    CLSD annual return on equity is 88.41%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CLSD price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CLSD price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.44
    CLSD price to book ratio is -0.44

    PB ratio Sector rank

    12.63%
    CLSD price to book ratio is higher than 12.63% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.15
    CLSD price to sales ratio is 5.15

    PS ratio Sector rank

    58.79%
    CLSD price to sales ratio is higher than 58.79% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $68.32M
    CLSD enterprise value is $68.32 million

    Enterprise value Sector rank

    42.18%
    CLSD enterprise value is higher than 42.18% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.17
    CLSD EV/EBITDA is -3.17

    EV/EBITDA Sector rank

    29.3%
    CLSD EV/EBITDA is higher than 29.3% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.44
    CLSD annual current ratio is 4.44

    Quick ratio

    4.44
    CLSD annual quick ratio is 4.44

    Leverage

    Debt to equity

    -1.35
    CLSD annual debt to equity ratio is -1.35

    Interest coverage ratio

    -
    CLSD annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    CLSD piotroski f-score is 2

    Altman Z-Score

    -22.53
    CLSD altman z-score is -22.53

    Analyst ratings

    Recent major analysts updates

    Jul 18, 25 HC Wainwright & Co.
    Neutral
    Jul 18, 25 Chardan Capital
    Neutral
    Jul 17, 25 Needham
    Hold
    May 23, 25 HC Wainwright & Co.
    Buy
    May 16, 25 JMP Securities
    Market Outperform
    May 15, 25 Needham
    Buy
    Apr 8, 25 Needham
    Buy
    Mar 31, 25 HC Wainwright & Co.
    Buy
    Mar 28, 25 Needham
    Buy
    Mar 28, 25 Citizens Capital Markets
    Market Outperform

    Institutional Ownership

    Screeners with CLSD included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    Earnings today
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Clearside Biomedical, Inc.?
    • Does Clearside Biomedical, Inc. pay dividends?
    • What sector is Clearside Biomedical, Inc. in?
    • What industry is Clearside Biomedical, Inc. in?
    • What country is Clearside Biomedical, Inc. based in?
    • When did Clearside Biomedical, Inc. go public?
    • Is Clearside Biomedical, Inc. in the S&P 500?
    • Is Clearside Biomedical, Inc. in the NASDAQ 100?
    • Is Clearside Biomedical, Inc. in the Dow Jones?
    • When was Clearside Biomedical, Inc.'s last earnings report?
    • When does Clearside Biomedical, Inc. report earnings?

    What is the ticker symbol for Clearside Biomedical, Inc.?

    The ticker symbol for Clearside Biomedical, Inc. is NASDAQ:CLSD

    Does Clearside Biomedical, Inc. pay dividends?

    No, Clearside Biomedical, Inc. does not pay dividends

    What sector is Clearside Biomedical, Inc. in?

    Clearside Biomedical, Inc. is in the Healthcare sector

    What industry is Clearside Biomedical, Inc. in?

    Clearside Biomedical, Inc. is in the Biotechnology industry

    What country is Clearside Biomedical, Inc. based in?

    Clearside Biomedical, Inc. is headquartered in United States

    When did Clearside Biomedical, Inc. go public?

    Clearside Biomedical, Inc.'s initial public offering (IPO) was on June 2, 2016

    Is Clearside Biomedical, Inc. in the S&P 500?

    No, Clearside Biomedical, Inc. is not included in the S&P 500 index

    Is Clearside Biomedical, Inc. in the NASDAQ 100?

    No, Clearside Biomedical, Inc. is not included in the NASDAQ 100 index

    Is Clearside Biomedical, Inc. in the Dow Jones?

    No, Clearside Biomedical, Inc. is not included in the Dow Jones index

    When was Clearside Biomedical, Inc.'s last earnings report?

    Clearside Biomedical, Inc.'s most recent earnings report was on May 8, 2025

    When does Clearside Biomedical, Inc. report earnings?

    The next expected earnings date for Clearside Biomedical, Inc. is September 15, 2025
    On this page